{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:12:41Z","timestamp":1790248361140,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jconrel.2018.05.021","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T22:11:13Z","timestamp":1526940673000},"page":"32-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Oral vitamin-A-coupled valsartan nanomedicine: High hepatic stellate cell receptors accessibility and prolonged enterohepatic residence"],"prefix":"10.1016","volume":"283","author":[{"given":"Nesrine S.","family":"El-Mezayen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessam F.","family":"El-Hadidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessam M.","family":"El-Refaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanaa I.","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman S.","family":"El-Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.05.021_bb0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000343852","article-title":"From cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence","volume":"2","author":"Ramakrishna","year":"2013","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S2468-1253(16)30110-8","article-title":"Antifibrotics in chronic liver disease: tractable targets and translational challenges","volume":"1","author":"Ramachandran","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0083-6729(06)75006-3","article-title":"Vitamin A-storing cells (stellate cells)","volume":"75","author":"Senoo","year":"2007","journal-title":"Vitam. Horm."},{"issue":"2823","key":"10.1016\/j.jconrel.2018.05.021_bb0020","article-title":"Fate-tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its etiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0025","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.23104","article-title":"Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice","volume":"50","author":"\u00d6sterreicher","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0030","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2006.10.018","article-title":"The renin\u2013angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin-(1\u20137)","volume":"46","author":"Pereira","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0035","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1053\/gast.2002.36561","article-title":"Up-regulation of components of the renin-angiotensin system in the bile duct\u2013ligated rat liver","volume":"123","author":"Paizis","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.510310117","article-title":"Peroxisome proliferator-activated receptor \u03b3 transcriptional regulation is involved in platelet-derived growth factor\u2013induced proliferation of human hepatic stellate cells","volume":"31","author":"Galli","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103786","article-title":"Role of vascular smooth muscle PPAR-\u03b3 in regulating AT1 receptor signaling and angiotensin II-dependent hypertension","volume":"9","author":"Carrillo-Sepulveda","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11239-012-0835-2","article-title":"Ang II induce kidney damage by recruiting inflammatory cells and up regulates PPAR gamma and Renin 1 gene: effect of \u03b2 carotene on chronic renal damage","volume":"36","author":"Kaliappan","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1524-6175.2005.05264.x","article-title":"The pleiotropic effects of angiotensin receptor blockers","volume":"8","author":"Chrysant","year":"2006","journal-title":"J. Clin. Hypertension"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0060","first-page":"89","article-title":"PPAR-gamma receptors, new therapeutic target in metabolic and cardiovascular diseases","volume":"60","author":"Scheen","year":"2005","journal-title":"Rev. Med. Liege"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320310370852","article-title":"Angiotensin II type 1 receptor blockers: class effects versus molecular effects","volume":"12","author":"Miura","year":"2011","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.mce.2008.06.006","article-title":"Sartan\u2013AT 1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism","volume":"302","author":"Van Liefde","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0075","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1291\/hypres.28.593","article-title":"Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling","volume":"28","author":"Takai","year":"2005","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0080","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.bbamem.2011.02.002","article-title":"Interactions of the AT 1 antagonist valsartan with dipalmitoyl-phosphatidylcholine bilayers","volume":"1808","author":"Potamitis","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0085","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/ncpcardio0805","article-title":"Beyond the classic angiotensin-receptor-blocker profile","volume":"5","author":"Kurtz","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0090","series-title":"Pharmacological and Pharmaceutical Profile of Valsartan: A Review","author":"Siddiqui","year":"2011"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0095","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1365-2362.2008.02025.x","article-title":"Angiotensin inhibition stimulates PPAR-\u03b3 and the release of visfatin","volume":"38","author":"Storka","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0100","first-page":"2","article-title":"Chromatographic separation and utilization of labeled 99m Tc-valsartan for cardiac imaging","volume":"4","author":"Sanad","year":"2014","journal-title":"J. Mol. Imag. Dynamic"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0105","first-page":"197","article-title":"The effects of renin-angiotensin system blockade on the liver steatosis in rats on long-term high-fat diet","volume":"47","author":"Chen","year":"2008","journal-title":"Zhonghua nei ke za zhi"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0110","first-page":"41","article-title":"Evaluation of the possible antifibrotic effect of aliskiren, valsartan, chloroquine, zafirlukast and colchicine on liver fibrosis induced by carbon tetrachloride in rats","volume":"2","author":"El-Kholi","year":"2015","journal-title":"Br. J. Med. Health Res."},{"issue":"18","key":"10.1016\/j.jconrel.2018.05.021_bb0115","article-title":"Valsartan blocks thrombospondin\/transforming growth factor\/Smads to inhibit aortic remodeling in diabetic rats","volume":"10","author":"Sun","year":"2015","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0120","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3748\/wjg.15.942","article-title":"Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis","volume":"15","author":"Georgescu","year":"2009","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/gast.2001.26288","article-title":"Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis","volume":"121","author":"Gonz\u00e1lez-Abraldes","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2017.09.035","article-title":"Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: a novel strategy with potent efficacy in experimental liver fibrosis","volume":"266","author":"El-Mezayen","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0135","first-page":"1483","article-title":"Valsartan loaded solid lipid nanoparticles: development, characterization and in vitro and ex vivo evaluation","volume":"4","author":"Parmar","year":"2011","journal-title":"Int. J. Pharm. Sci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0140","first-page":"229","article-title":"Development and validation of new UV-spectrophotometric assay method for valsartan in pure and in formulations","volume":"5","author":"Rao","year":"2013","journal-title":"J. Chem. Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0145","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1152\/ajpendo.00596.2014","article-title":"Uterine artery dysfunction in pregnant ACE2 knockout mice is associated with placental hypoxia and reduced umbilical blood flow velocity","volume":"309","author":"Yamaleyeva","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0150","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/15321819.2011.647189","article-title":"Determination of PPAR-\u03b3 activity in adipose tissue and spleen","volume":"33","author":"Chan","year":"2012","journal-title":"J. Immunoass. Immunochem."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0155","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.2147\/IJN.S71891","article-title":"Fabrication and evaluation of valsartan\u2013polymer\u2013surfactant composite nanoparticles by using the supercritical antisolvent process","volume":"9","author":"Kim","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A\u2013coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0165","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.3892\/mmr.2015.3842","article-title":"Inhibition of liver fibrosis using vitamin A-coupled liposomes to deliver matrix metalloproteinase-2 siRNA in vitro","volume":"12","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"36","key":"10.1016\/j.jconrel.2018.05.021_bb0170","article-title":"Liposomal delivery systems for intestinal lymphatic drug transport","volume":"20","author":"Ahn","year":"2016","journal-title":"Biomater. Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0005-2736(95)00219-7","article-title":"Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes","volume":"1278","author":"Friend","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2012.02.011","article-title":"Drug targeting to the diseased liver","volume":"161","author":"Poelstra","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2018.05.021_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/08982108809035984","article-title":"Life-long administration of liposomes and lipid A in mice: effects on longevity, antibodies to liposomes, and terminal histopathological patterns","volume":"1","author":"Richardson","year":"1988","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0190","doi-asserted-by":"crossref","first-page":"1): 1","DOI":"10.1016\/S0168-3659(01)00545-4","article-title":"A cationic sub-micron emulsion (MF59\/DOTAP) is an effective delivery system for DNA vaccines","volume":"79","author":"Ott","year":"2002","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2018.05.021_bb0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.gt.3300390","article-title":"Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"4","author":"Porteous","year":"1997","journal-title":"Gene Ther."},{"issue":"8","key":"10.1016\/j.jconrel.2018.05.021_bb0200","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/gt.2017.41","article-title":"Engineering liposomal nanoparticles for targeted gene therapy","volume":"24","author":"Zylberberg","year":"2017","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2018.05.021_bb0205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000226912","article-title":"Safety of high-dose vitamin A","volume":"48","author":"Pastorino","year":"1991","journal-title":"Oncology"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0731-7085(01)00413-7","article-title":"pK a determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry","volume":"26","author":"Cagigal","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0215","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijpharm.2012.05.076","article-title":"Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique","volume":"434","author":"Cao","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0225","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0022-2275(20)37552-0","article-title":"Plasma kinetics of vitamin A in humans after a single oral dose of [8, 9, 19-13C] retinyl palmitate","volume":"37","author":"Reinersdorff","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0230","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0022-2275(20)34310-8","article-title":"A multicompartmental model of vitamin A kinetics in rats with marginal liver vitamin A stores","volume":"26","author":"Green","year":"1985","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0235","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.3748\/wjg.v18.i28.3635","article-title":"Cellular and molecular mechanisms of intestinal fibrosis","volume":"18","author":"Speca","year":"2012","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1247\/csf.1.201","article-title":"The possible existence of a vitamin A-storing cell system","volume":"1","author":"Yamada","year":"1976","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0245","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0022-2275(20)37232-1","article-title":"Storage of vitamin A in extrahepatic stellate cells in normal rats","volume":"38","author":"Nagy","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0250","first-page":"784","article-title":"Retinitis pigmentosa in abetalipoproteinemia: effects of vitamin A","volume":"10","author":"Gouras","year":"1971","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0255","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/jn\/117.4.694","article-title":"Variation in retinol utilization rate with vitamin A status in the rat","volume":"117","author":"Green","year":"1987","journal-title":"J. Nutr."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0260","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0022-2275(20)42338-7","article-title":"Retinol metabolism in rats with low vitamin A status: a compartmental model","volume":"31","author":"Lewis","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0265","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3748\/wjg.v22.i4.1348","article-title":"Hepatic non-parenchymal cells: master regulators of alcoholic liver disease?","volume":"22","author":"Seo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cyto.990070407","article-title":"Flow cytometric analysis of liposome-nuclei interaction: transfer and intranuclear release of carboxyfluorescein","volume":"7","author":"Papa","year":"1986","journal-title":"Cytometry A"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0275","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1023\/A:1016026101195","article-title":"Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids","volume":"13","author":"Zelphati","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0280","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/pr.58.1.8","article-title":"Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery","volume":"58","author":"Khalil","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0285","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20080647","article-title":"Angiotensin-(1\u20137), an alternative metabolite of the renin\u2013angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat","volume":"117","author":"Lubel","year":"2009","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0290","first-page":"125","article-title":"Role of the vasodilator peptide angiotensin-(1\u20137) in cardiovascular drug therapy","volume":"3","author":"Schindler","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0295","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","article-title":"G-protein\u2013coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor","volume":"111","author":"Kostenis","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0300","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.HYP.30.3.549","article-title":"Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats","volume":"30","author":"Britto","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0305","article-title":"Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings","volume":"1","author":"Panebianco","year":"2016","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0310","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/excr.1994.1009","article-title":"The expression of retinoid X receptor genes is regulated by all-trans-and 9-cis-retinoic acid in F9 teratocarcinoma cells","volume":"210","author":"Wan","year":"1994","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0315","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1476-5926-2-S1-S7","article-title":"PPAR gamma and hepatic stellate cells","volume":"3","author":"Hazra","year":"2004","journal-title":"Comp. Hepatol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0320","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","article-title":"Experimental liver fibrosis research: update on animal models, legal issues and translational aspects","volume":"6","author":"Liedtke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/srep18300","article-title":"Attrition of hepatic damage inflicted by angiotensin II with \u03b1-tocopherol and \u03b2-carotene in experimental apolipoprotein E knock-out mice","volume":"5","author":"Gopal","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0330","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M112.366419","article-title":"The Peroxisome Proliferator-Activated Receptor \u03b3 (PPAR-\u03b3) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis","volume":"287","author":"Benedusi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0335","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S","article-title":"Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells","volume":"187","author":"Inagaki","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0340","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/mol.106.022954","article-title":"Peroxisome proliferator-activated receptor-\u03b3 and retinoic acid X receptor \u03b1 represses the TGF\u03b21 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation","volume":"70","author":"Lee","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0345","article-title":"Angiotensin-(1\u20137) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects","volume":"289","author":"Iwata","year":"2005","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0350","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1386-6346(01)00102-4","article-title":"Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats","volume":"21","author":"Ohishi","year":"2001","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0355","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11596-008-0512-z","article-title":"Telmisartan but not valsartan inhibits TGF-\u03b2-mediated accumulation of extracellular matrix via activation of PPAR-\u03b3","volume":"28","author":"Yao","year":"2008","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0360","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jcmm.12551","article-title":"Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-\u03b21 and HIF-1\u03b1 in Ang II-mediated fibrosis after myocardial infarction","volume":"19","author":"Sui","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0365","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1177\/1535370215576312","article-title":"Angiotensin II increases matrix metalloproteinase 2 expression in human aortic smooth muscle cells via AT1R and ERK1\/2","volume":"240","author":"Wang","year":"2015","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0370","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/HYPERTENSIONAHA.114.03388","article-title":"Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II\u2013induced loss of vascular smooth muscle cells and adverse vascular remodelingNovelty and significance","volume":"64","author":"Patel","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0375","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1681\/ASN.2004040278","article-title":"Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts","volume":"16","author":"Zafiriou","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2018.05.021_bb0380","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/thorax.58.9.778","article-title":"Inhibition of MMP-9 expression by PPAR-\u03b3 activators in human bronchial epithelial cells","volume":"58","author":"Hetzel","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0385","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/jhep.2001.28231","article-title":"Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats","volume":"34","author":"Yoshiji","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2018.05.021_bb0390","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1499-3872(11)60009-X","article-title":"Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats","volume":"10","author":"Wang","year":"2011","journal-title":"Hepat. Pancreat. Dis. Int."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918302864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918302864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:35:06Z","timestamp":1759160106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918302864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":78,"alternative-id":["S0168365918302864"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.021","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral vitamin-A-coupled valsartan nanomedicine: High hepatic stellate cell receptors accessibility and prolonged enterohepatic residence","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}